kongre.net
Welcome to kongre.net
EA
CourseIn person

ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano

Hosted by European Society for Medical Oncology

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net
Welcome to kongre.net
Official website (opens in a new tab)

Key facts

ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano is a course held 23 – 24 March 2027 in Lugano, Switzerland, organised by European Society for Medical Oncology.

Dates:
23 – 24 March 2027
Format:
In person
Venue:
Lugano, Switzerland
Subjects:
Oncology & Cancer Research
Organiser:
European Society for Medical Oncology
Official website:
esmo.org/meeting-calendar/esmo-advanced-course-on-the-evolving-role-of-cdk4-6-inhibitors-in-hormone-receptor-positive-her2-negative-early-and-advanced-breast-cancer-2027-lugano
An advanced course focusing on the evolving role of CDK4/6 inhibitors in hormone receptor positive HER2 negative early and advanced breast cancer.

Conference theme

Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer

Organising Committee

Matteo Lambertini - Chair, Ente Ospedaliero Ospedali Galliera, University of Genova, Italy Barbara Pistilli - Chair, Gustave Roussy, France
Venue & travel Lugano, SwitzerlandVenue detailsAbout the organiser European Society for Medical Oncology4 more events from this organiserOrganiser profileWho is going? See who is planning to attend and say you are goingSee who is going

Organiser and contact

Host organisation

European Society for Medical Oncology4 more events from European Society for Medical Oncology

Contact

Email:
[email protected]

Advertisement

Related events